Literature DB >> 18542788

Sunitinib, sorafenib and other systemic noncytotoxic kidney cancer therapies can and should be administered by urologists.

Laurence Klotz1.   

Abstract

Entities:  

Year:  2007        PMID: 18542788      PMCID: PMC2422950          DOI: 10.5489/cuaj.70

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  1 in total

1.  Recurrent renal cell cancer: 10 years or more after nephrectomy.

Authors:  Emmanuel Abara; Iolanda Chivulescu; Nilam Clerk; Pablo Cano; Alexis Goth
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.